Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a light cap lift bipolar depression?

NCT ID NCT07510646

Symptom relief Sponsor: Vielight Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable light device (Vielight RX Gamma) that shines light on the brain to see if it safely eases bipolar depression symptoms. Forty people with bipolar disorder will either get the active device or a sham (inactive) one, using it in the clinic 5 days a week for 6 weeks. Researchers will track changes in mood, thinking, pain, and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Diagnosis of bipolar depression * Montgomery-Asberg Depression Rating Scale (MADRS) of 24 or higher * Capable of providing consent * Currently inpatient or outpatient * Ability to communicate in spoken and written English fluently enough to complete the required study assessments Exclusion Criteria: * Currently in manic or mixed episode, as measured by Young Mania Rating Scale (YMRS) more than 8-10 * Currently psychotic * Judged to be at serious and imminent suicidal risk * Currently has alcohol or substance use disorder (meeting criteria in the past 1 months) * Unstable medical conditions * Inability to consent or to complete study procedures * Changes in medications or use of augmentative devices and other interventions in the 4 weeks prior to the study * Participation in other clinical research trials that may influence primary outcomes or adherence to the proposed study * Current pregnancy or intention to become pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bipolar depression bipolar disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bipolar Bipolar disorder (BD) Bipolar disorder depression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Providence Care Hospital

    Kingston, Ontario, K7L 4X3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.